Skip to main content

Inovio stock plunges after U.S. government pulls funding for late-stage testing of Covid-19 vaccine candidate

The Plymouth Meeting biotechnology company has been working on its potential Covid-19 vaccine since early 2020.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.